Fujifilm has announced that it is acquiring Irvine Scientific Sales Company (ISUS) and IS Japan (ISJ), leading companies in cell culture media.

The Japanese photography and imaging company has signed a stock purchase agreement worth an estimated $800m and will acquire all outstanding shares of both companies. The company will complete the deal by June. Both companies were previously owned by Japanese oil and energy company JXTG.

Culture medium is a solid, liquid or semi-solid designed to support the growth of microorganisms or cells. The two companies have developed a range of products including culture media for biopharmaceutical production, in vitro fertilisation and cell therapy.

ISUS distributes mainly in the US and Europe, while ISJ distributes mainly in Japan and other countries in Asia, providing culture media to pharmaceutical companies, bio-ventures, and academia.

The market for cell culture media is expanding following a growth in the demand for biopharmaceuticals centred on antibody drugs and the increasing need for treatments using cells. Its annual growth is expected to be approximately 10% going forward.

In a statement, Fujifilm explained that the aim of the acquisition was to advance its growth strategies in the healthcare area: “By combining the Fujifilm Group’s bio-medical-related technologies and products with the cell culture media technologies and products of ISUS and ISJ, the company will maximise the synergies in areas other than the cell culture media business as well.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“The expected synergies are: the further expansion of the contact development and manufacturing business for biopharmaceuticals, the acceleration of research and development in the area of regenerative medicine, and the further expansion of reagent business.”

In 2011, the company acquired MSD Biomanufacturing Network . 

Fujifilm also purchased US biotechnology company Cellular Dynamics International in 2015 for $307m and Wako Pure Chemical Industries in 2016. The company is also planning a $6.1bn acquisition of Xerox Corp.